The move will allow HIMSS Analytics' clients to access HIMSS' data as well as Definitive's proprietary data.
Framingham, Massachusetts-based Definitive Healthcare has bought HIMSS Analytics' vendor data services business, the health information services company announced Wednesday morning.
As part of the deal, Definitive has purchased HIMSS' subsidiaries including Logic, Predict, Analyze, and additional custom research products.
The acquisition is final and Definitive will now undergo the process of integrating HIMSS' "datasets and platform functionality," while also improving "coverage of IT purchasing intelligence."
Jason Krantz, CEO of Definitive Healthcare, told HealthLeaders that the deal is primarily about product innovation and gaining new assets around technology infrastructure.
"[The acquisition] goes along with the theme of what we've been doing, which is continuing to innovate and come up with new datasets to help our clients," Krantz said.
He added that the goal of the acquisition was to provide clients with a central location to understand various aspects of the healthcare provider market, citing the benefit for HIMSS Analytics' clients to have access to both the scale of HIMSS' data as well as Definitive's proprietary data.
"We identified Definitive Healthcare as the ideal strategic buyer early in the process,” Blain Newton, executive vice president of HIMSS Analytics, said in a statement. “I can truly say that the combined power of the Definitive Healthcare and HIMSS Analytics data assets creates a solution of never-before-seen value for health care. Our two teams are working closely together to ensure the highest level of service is provided to clients during and well-beyond this transition."
With regards to value proposition, Krantz said that Definitive has rolled out a product with 210 million patient lives with commercial claims data associated with them so clients can utilize the data to understand procedure, diagnosis, and volume by provider and physician. He added that the company will unveil a clinical trial database in February.
Jack O'Brien is the finance editor at HealthLeaders, a Simplify Compliance brand.